iBio, Inc.
Balance Sheet
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $56.4M | $8.6M | $14.2M | $4.3M | $22.7M | $77.4M | $55.1M | $4.4M |
| Accounts Receivable | — | — | $0 | $0 | $1.0M | $426.0K | $75.0K | $97.0K |
| Inventory | — | — | $0 | $0 | $3.9M | $27.0K | — | — |
| Total Current Assets | $92.2M | $9.7M | $15.7M | $26.3M | $45.1M | $104.6M | $61.7M | $4.8M |
| Property, Plant & Equipment | $3.1M | $3.2M | $3.6M | $4.2M | $1.4M | $8.6M | $3.7M | $24.4M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $1.8M | $6.8M | $5.4M | $5.4M | $4.9M | $952.0K | $1.1M | $1.4M |
| Total Assets | $99.1M | $23.2M | $28.7M | $41.2M | $99.4M | $147.0M | $94.2M | $30.6M |
| Liabilities | ||||||||
| Accounts Payable | $4.4M | $2.2M | $358.0K | $1.8M | $4.3M | $2.3M | $1.8M | $1.0M |
| Total Current Liabilities | $11.7M | $6.1M | $3.8M | $22.1M | $30.4M | $6.6M | $5.2M | $3.5M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $13.4M | $8.3M | $7.4M | $25.8M | $35.9M | $38.4M | $37.6M | $28.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-365.3M | $-332.2M | $-313.8M | $-288.9M | $-223.9M | $-173.6M | $-150.4M | $-105.8M |
| Total Stockholders' Equity | $85.7M | $14.9M | $21.3M | $15.4M | $63.5M | $108.6M | $56.6M | $2.5M |